Poxet, which contains the active ingredient dapoxetine, is primarily prescribed for the treatment of premature ejaculation (PE), not benign prostatic hyperplasia (BPH). However, in some cases, men with BPH may also suffer from PE or other forms of sexual dysfunction, prompting concurrent use of medications like Poxet. Though not a standard treatment for BPH, Poxet’s selective serotonin reuptake inhibition may indirectly benefit urinary symptoms by improving control over ejaculation and reducing performance anxiety. That said, Poxet is not FDA-approved for BPH treatment, and its use in this context is considered off-label. For BPH, drugs like tamsulosin or finasteride are typically preferred. Always consult a healthcare provider before using Poxet for any condition outside its approved use.
 |
M'inscrire 
Me connecter 
Mot de passe oublié 
Retour au forum
